UPAD.L
iShares S&P 500 Paris-Aligned Climate UCITS ETF USD Dist
LSEUSDETF / FUND
DELAYED
Last price
9.20
▼ 0.01 (0.12%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Tool
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
—
Prev close
9.21
Day high
0.00
Day low
0.00
Volume
1
Market cap
—
P/E (TTM)
0.27
52W range
0.00 – 9.32
Trailing performance
Returnvs SPY
1W
-0.74%
+0.6%
1M
+6.21%
+2.5%
3M
+3.50%
+0.4%
6M
+12.68%
+1.6%
YTD
+9.05%
-3.2%
1Y
+15.60%
-4.4%
3Y
+72.16%
-2.0%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Top holdings
Sector exposure
Technology
42.81%
Financial services
12.62%
Communication services
10.83%
Consumer cyclical
9.65%
Healthcare
9.52%
Industrials
6.30%
Consumer defensive
4.41%
Real estate
1.94%
Basic materials
1.28%
Utilities
0.65%
Fund profile
Fund familyBlackRock Asset Management Ireland - ETF
Category—
Legal typeExchange Traded Fund
Expense ratio0.00%
Turnover0.0%
Total net assets$562.59M
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on UPAD.L open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Fundamentals
Market cap—
Enterprise value—
Revenue (TTM)—
Gross profit—
EBITDA—
Net income—
EPS (TTM)—
Free cash flow—
Total cash—
Total debt—
Book value / share—
Shares outstanding—
Float—
Short % of float—
Dividend yield—
Beta (5Y)—
Valuation & profitability ratios
Trailing P/E0.27
Forward P/E—
PEG ratio—
Price / sales—
Price / book—
EV / revenue—
EV / EBITDA—
Gross margin—
Operating margin—
Profit margin—
Return on equity—
Return on assets—
Debt / equity—
Current ratio—
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
Consensus—
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders—
Held by institutions—
Institutions holding—
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
9.23
-0.33% from price
SMA 20
9.10
+1.07% from price
SMA 50
8.93
+2.98% from price
SMA 100
8.73
+5.36% from price
SMA 200
8.48
+8.49% from price
EMA 12
9.18
+0.17% from price
EMA 26
9.08
+1.24% from price
EMA 50
8.96
+2.61% from price
RSI (14)
58.6
Neutral
MACD (12,26,9)
0.10
Hist -0.01
ATR (14)
0.05
0.53% of price
Realised vol 30D
13.2%
Annualised
Bollinger upper
9.50
20, 2σ
Bollinger lower
8.70
20, 2σ
50 / 200 cross
Golden
8.93 vs 8.48
Trend bias
Above 200
+8.49%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.27
Less volatile than market
Correlation to SPY
0.28
Largely independent
Realised vol 30D
13.2%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-11.2%
Peak to trough
Max drawdown 5Y
-19.3%
Peak to trough
ATR 14
0.05
0.53% of price
Beta (reported)
—
5Y monthly, from filing
Headlines
The Committee for a Responsible Federal Budget Estimates Social Security Cuts for Couples if the System Is Not Fixed
Motley Fool · 15m ago
Zoetis Earnings Reveal a Divided Business, But Can its Pipeline Restore Growth?
Insider Monkey · 15m ago
Liverpool striker Isak expected Newcastle abuse, says Iraola
AFP · 16m ago
Your mortgage rate has a growing problem in the bond market
TheStreet · 18m ago
Medtronic vs. Tenet Healthcare: Which Healthcare Stock Offers Better Long-Term Growth?
Insider Monkey · 22m ago
FHLC vs. PJP: Which Healthcare ETF Is the Better Buy for Investors?
Motley Fool · 25m ago
Vistra Is the Quietest Big Winner of the AI Power Boom. Here's Why.
Motley Fool · 26m ago
AstraZeneca Made a $1.5 Billion Lung Cancer Bet, but Can Zegfrovy Strengthen its Oncology Growth?
Insider Monkey · 26m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.